- Previous Close
7.22 - Open
7.24 - Bid 7.22 x --
- Ask 7.23 x --
- Day's Range
7.19 - 7.27 - 52 Week Range
5.93 - 8.68 - Volume
24,676,372 - Avg. Volume
49,106,394 - Market Cap (intraday)
47.926B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
25.79 - EPS (TTM)
0.28 - Earnings Date --
- Forward Dividend & Yield 0.07 (0.93%)
- Ex-Dividend Date Sep 30, 2024
- 1y Target Est
6.40
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
www.raas-corp.comRecent News: 002252.SZ
View MorePerformance Overview: 002252.SZ
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002252.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002252.SZ
View MoreValuation Measures
Market Cap
47.93B
Enterprise Value
44.22B
Trailing P/E
25.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.65
Price/Book (mrq)
1.54
Enterprise Value/Revenue
5.30
Enterprise Value/EBITDA
19.56
Financial Highlights
Profitability and Income Statement
Profit Margin
21.93%
Return on Assets (ttm)
4.32%
Return on Equity (ttm)
6.00%
Revenue (ttm)
8.34B
Net Income Avi to Common (ttm)
1.83B
Diluted EPS (ttm)
0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
3.71B
Total Debt/Equity (mrq)
0.00%
Levered Free Cash Flow (ttm)
103.73M